Skip to content
V0992-25 ·11 June 2025 ·consulta-vinculante Medium impact
Tax

Manufacture of human immunological medicines falls under IAE heading 254.2

A company asked whether the manufacture of human immunological medicines should be taxed under IAE heading 254.1 or 254.2. The DGT confirms that, as these are immediate medicinal products without further processing, the correct heading is 254.2.

In 6 key points

Lifecycle

2025-06-11PublishedPublished in the BOE
Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The tax team reviews your specific situation.

Talk to the tax team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact